Hippocratic AI Partners with Fivetran to Strengthen Data Infrastructure for Patient Care Platform

The collaboration is designed to help Hippocratic AI protect sensitive production systems, accelerate data analysis, and establish scalable infrastructure.

Hippocratic AI, a generative AI company focused on large language models for healthcare, has partnered with Fivetran, a data analysis firm, to build a secure data foundation aimed at advancing its patient care platform.

The collaboration is designed to help Hippocratic AI protect sensitive production systems, accelerate data analysis, and establish scalable infrastructure. Through the partnership, the company will be able to replicate customer data in an analytical environment that complies with healthcare regulatory standards and regional data residency requirements.

According to Fivetran, the integrated environment will support global research, benchmarking, and real-time operational decision-making.

"With Fivetran, we have added data resilience to systems while establishing a foundation that lets us move faster, scale securely and deliver actionable insights to our customers," said Matt Honea, chief information security officer of Hippocratic AI.

The partnership marks the latest in a series of initiatives by Hippocratic AI to expand its healthcare technology capabilities. In September, the company joined hands with Eraas Health to combine analytics and generative AI for identifying individuals at high health risk. The collaboration leverages Hippocratic AI’s Polaris Constellation System to generate health insights.

The same month, University Hospitals collaborated with Hippocratic AI to integrate its conversational agents within clinical workflows and patient engagement processes. These voice-based agents are being used for a range of non-diagnostic support applications.

In August, Hippocratic AI was among over 60 organizations — including Amazon, Apple, Google, OpenAI, and Oura, to join the CMS Aligned Network under the CMS Interoperability Framework.

Earlier this year, the company raised $141 million in a Series B funding round, bringing its valuation to $1.64 billion. The announcement was accompanied by the launch of the Healthcare AI Agent App Store, enabling clinicians to co-develop AI agents for specific patient needs.

On the other side, Fivetran recently entered into an all-stock merger agreement with dbt Labs, with George Fraser appointed as CEO of the unified entity and Tristan Handy as president. In another update, Fivetran announced the general availability of its Oracle Binary Log Reader, a new replication method designed for high-volume, real-time data transfer.

The company reported surpassing $300 million in annual recurring revenue in 2024, marking a steady increase from $200 million in 2023.

Stay tuned for more such updates on Digital Health News